Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$6.69 USD
+0.14 (2.14%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $6.73 +0.04 (0.60%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.69 USD
+0.14 (2.14%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $6.73 +0.04 (0.60%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
Zacks News
Zacks.com featured highlights include: Dave & Buster's Entertainment, Sensus Healthcare and Sociedad Quimica y Minera de Chile
by Zacks Equity Research
Zacks.com featured highlights include: Dave & Buster's Entertainment, Sensus Healthcare and Sociedad Quimica y Minera de Chile
3 Top-Ranked Stocks to Buy for Solid Earnings Acceleration
by Tirthankar Chakraborty
Dave & Buster's (PLAY), Sensus Healthcare (SRTS) & Sociedad Quimica y Minera (SQM) are worth buying now for superb earnings acceleration.
After Golden Cross, Sensus Healthcare, Inc. (SRTS)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Sensus Healthcare, Inc. (SRTS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 200.00% and 2.70%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Sensus Healthcare, Inc. (SRTS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 60.00% and 33.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Sensus Healthcare, Inc. (SRTS) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 22.22% and -22.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare, Inc. (SRTS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.